• we cover more than 1,000 news per day, in 2 languages, and 83,000 stocks
Light Dark
it
italian it
english en

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

www.businesswire.com 05-12-2024 02:00 0.5 Minutes reading
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren’t slowing down interest in popular drugs used for weight loss such as Mounjaro, Ozempic, Wegovy, and Zepbound. In fact, some of these p

Info

Related news
Glancy Prongay & Murray LLP Reminds Investors...
26.12.24 05:42
by businesswire.com

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class A...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSE: SUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”). If you suffered a loss on your Sun Communities investments or would like to inquire abo

Sentiment
0
Bearish/Bullish
50